# Ambrisentan

NDC: 69097-387
Generic name: Ambrisentan
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190426

FDA application: ANDA210715

## Active ingredients

- AMBRISENTAN: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-387"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-387
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0e418384-cae1-47ae-ac5e-afc845d694f6